Analysis of the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023
Technology Advances and New Radiopharmaceuticals Maintain the Industry on a Growth Track
06-Mar-2017
North America
Market Research
K0A6-01-00-00-00
HC02728-NA-MR_19502
Molecular imaging can easily be described as the next frontier of medical imaging. In an era of value-based reimbursement, molecular imaging is set to play a significant role in quicker diagnosis, more accurate disease staging, and selection of targeted treatments. Launch of new radiopharmaceuticals across clinical areas other than cardiology and oncology such as neurology and orthopedics is also expected to drive greater adoption of molecular imaging as part of clinical care pathways.
However, molecular imaging continues to face several challenges, notably the high cost of molecular imaging modalities and image scans, competition from lower cost modalities such as CT and MRI, and concerns over future supply of Tc-99m, a key SPECT radiopharmaceutical used for cardiac scans. This study analyzes existing trends in the hybrid molecular imaging and diagnostic radiopharmaceuticals markets with an emphasis on understanding strategies employed by market participants to address these myriad challenges. It also assesses both these markets in the context of changing regulatory and reimbursement policies in order to provide future market trends. This analysis will be critical in helping market participants create long-term viable strategies in order to remain competitive and ensure continuous innovation.
This deliverable assesses future trends in molecular imaging equipment revenues as well as growth in the number of unit shipments over the next few years. This will provide value to market participants that design and manufacture molecular imaging equipment. Market participants will also be provided insights on recent industry and technology trends that are shaping the molecular imaging market. Radiopharmaceutical manufacturers will be provided with key insights on the evolving usage trends of workhorse FDG and Tc-99m radiopharmaceuticals and the increasing adoption of new radiopharmaceuticals across new clinical areas. Companies that are in the process of developing software to improve quantitation accuracy, lower dosages, and reduce scan times for both PET and SPECT will be provided with key insights on how the molecular imaging market is growing as well as the factors that are required to facilitate greater adoption of PET and SPECT technologies.
Research Methodology
Scope of This Study
Key Findings
Market Engineering Measurements—PET/CT
Market Engineering Measurements—SPECT/CT
Market Engineering Measurements—PET/MR
Key Findings
Market Engineering Measurements—PET
Market Engineering Measurements—SPECT
Scope of the Study—Molecular Imaging
Scope of the Study—Radiopharmaceuticals
Molecular Imaging—Segmentation
Molecular Imaging—Definition
Shift in Focus from Standalone to Hybrid Imaging
Radiopharmaceuticals—Definitions
Segmentation of Radiopharmaceuticals
Distribution of Radiopharmaceuticals
US Radiopharmacy Facility Landscape 2016
Market Drivers
Improvements in Quantitation Accuracy
Role of Molecular Imaging in Personalized Medicine
Molecular Imaging Entering Into New Therapeutic Areas
Market Restraints
Affordability of Hybrid Modalities Will Remain Key Issue
Consolidations of Healthcare Providers
Changing Hospital Procurement Models
Market Engineering Measurements
Unit Shipment Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis
Market Engineering Measurements
Unit Shipment Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis
Market Engineering Measurements
Unit Shipment Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis
Analysis of Hybrid Molecular Imaging Products
Actively Marketed PET/CT Products in 2016
Actively Marketed PET/MR Products in 2016
Actively Marketed SPECT/CT Products in 2016
Digital PET—The Next Chapter in Nuclear Imaging
GE Healthcare—Key Technology Trends
GE Debuts DiscoveryTM MI PET/CT at SNMMI 2016
Launch of Discovery IQ PET/CT by GE
GE Launches First General Purpose Digital SPECT/CT
Siemens Debuts Mobile Biograph Horizon PET/CT
Siemens Debuts Latest Version of syngo.via
NeuSoft
Toshiba America Medical Systems
Molecular Dynamics
UltraSPECT
Upgradeability and Intra Modality Competition
Nuclear Medicine Physicians Face Employment Challenges
Technology Trends—PET/CT & SPECT/CT
Industry Trends—Advancements in Brain Imaging Using SPECT
Industry Trends—PET Scanning and Alzheimer’s Disease
Industry Trends—CMS Approves Funding for PET Amyloid Study
Industry Trends—Myocardial Perfusion Imaging: PET vs. SPECT
Market Drivers
Development of New Radiopharmaceuticals
Adopting a Cyclotron-based Approach
Mo-99 Production—Key Challenges and Potential Solutions
Market Restraints
Pricing and Reimbursement of Tc-99m—Key Challenges
High Entry Barriers Limit the Number of Participants
Market Engineering Measurements
Procedure Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis
Market Engineering Measurements
Procedure Forecast
Revenue Forecast
Trend Analysis
Market Share
Market Share Analysis
Analysis of PET and SPECT Radiopharmaceuticals
Key Market Participants and Main Product Lines
Siemens PETNET
IBA Molecular
Ionetix
Jubilant Draximage Develops Rubidium Generator
Northstar Medical Isotopes to Produce Mo-99
FDA Approves Gallium 68 Dotatate Kit—NETSPOT
FDA Approves Axumin PET Radiopharmaceutical
Axumin—Safety and Efficacy Parameters
CMS Rejection of NaF—18 PET Scan Reimbursement
Cardiac PET Perfusion Agents Industry—A Snapshot
Role of Radiopharmaceuticals in Oncology Clinical Trials
18F-CFA—The Next Frontier in Cancer Treatment
New PET Tracers for Clinical Use in Oncology
The Last Word—3 Big Predictions: Molecular Imaging
The Last Word—3 Big Predictions: Radiopharmaceuticals
Legal Disclaimer
Glossary of Terms—Molecular Imaging
Glossary of Terms—Radiopharmaceuticals
Market Engineering Methodology
Reimbursement of Procedures Involving Use of Radiopharmaceuticals and Molecular Imaging Modalities
Reimbursed Radiopharmaceuticals Billing Codes
- 1. Total Molecular Imaging Equipment Market: Key Market Drivers, US, 2017–2023
- 2. Total Molecular Imaging Equipment Market: Key Market Restraints, US, 2017–2023
- 3. PET/CT Equipment Segment: Market Engineering Measurements, US, 2016
- 4. SPECT/CT Equipment Segment: Market Engineering Measurements, US, 2016
- 5. PET/MR Equipment Segment: Market Engineering Measurements, US, 2016
- 6. Total Radiopharmaceuticals Market: Key Market Drivers, US, 2017–2023
- 7. Total Radiopharmaceuticals Market: Key Market Restraints, US, 2017–2023
- 8. PET Radiopharmaceuticals Segment: Market Engineering Measurements, US, 2016
- 9. SPECT Radiopharmaceuticals Segment: Market Engineering Measurements, US, 2016
- 1. PET/CT Equipment Segment: Market Engineering Measurements, US, 2016
- 2. SPECT/CT Equipment Segment: Market Engineering Measurements, US, 2016
- 3. PET/MR Equipment Segment: Market Engineering Measurements, US, 2016
- 4. PET Radiopharmaceuticals Segment: Market Engineering Measurements, US, 2016
- 5. SPECT Radiopharmaceuticals Segment: Market Engineering Measurements, US, 2016
- 6. PET/CT Equipment Segment: Unit Shipment Forecast, US, 2013–2023
- 7. PET/CT Equipment Segment: Revenue Forecast, US, 2013–2023
- 8. PET/CT Equipment Segment: Percent of Sales, US, 2016
- 9. SPECT/CT Equipment Segment: Unit Shipment Forecast, US, 2013-2023
- 10. SPECT/CT Equipment Segment: Revenue Forecast, US, 2013–2023
- 11. SPECT/CT Equipment Segment: Percent of Sales, US, 2016
- 12. PET/MR Equipment Segment: Unit Shipment Forecast, US, 2013–2023
- 13. PET/MR Equipment Segment: Revenue Forecast, US, 2013–2023
- 14. PET/MR Equipment Segment: Percent of Sales, US, 2016
- 15. PET Radiopharmaceuticals Segment: Procedure Forecast, US, 2013–2023
- 16. PET Radiopharmaceuticals Segment: Revenue Forecast, US, 2013-2023
- 17. PET Radiopharmaceuticals Segment: Percent of Sales, US, 2016
- 18. SPECT Radiopharmaceuticals Segment: Procedure Forecast, US, 2013–2023
- 19. SPECT Radiopharmaceuticals Segment: Revenue Forecast, US, 2013–2023
- 20. SPECT Radiopharmaceuticals Segment: Percent of Sales, US, 2016
Speak directly with our analytics experts for tailored recommendations.
Recent related Medical Imaging & Informatics research
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
05 Oct 2026 | Global | Frost Radar
Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026
The point-of-care ultrasound imaging industry is undergoing a fundamental transformation from equipment-intensive ultrasound to portable, handheld, wireless, AI-enabled, and connected point-of-care solutions. Driven by the need for rapid bedside diagnosis and decentralized healthcare delivery, speci...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.